Ca
Many of the intracellular actions of Ca 2ϩ in eukaryotic cells are mediated by activation of the family of Ca 2ϩ /calmodulindependent protein kinases (CaMKs), 1 that include the monofunctional enzymes, myosin light chain kinase (MLCK) and phosphorylase kinase, and the multi-functional enzymes, CaMKI, CaMKII, and CaMKIV (1) (2) (3) (4) (5) (6) . New members of the family continue to be characterized, including CaMK kinases (CaMKKs) that phosphorylate and activate CaMKI and CaMKIV as part of a kinase cascade (7) (8) (9) (10) (11) (12) (13) (14) (15) . A number of novel CaM kinases of unknown function also have been described recently (16, 17) . Elongation factor 2 kinase (EF2 kinase), originally thought to represent a member of this family, now appears to be related to a distinct class of protein kinases (18 -21) .
The CaMKs share many common structural and regulatory features. They each have a catalytic domain that is relatively highly conserved (ϳ40 -50% amino acid identity) and a COOHterminal regulatory domain that is not as highly conserved among family members (3) (4) (5) (6) . Like cAMP-dependent protein kinase (PKA) and protein kinase C (PKC), the CaMKs are maintained in an inactive state by an intrasteric autoinhibitory mechanism (6, (22) (23) (24) (25) (26) (27) (28) , a central feature of which is that amino acid residues within the regulatory domain bind to the active site of the kinases and sterically block the access of substrates. The CaMKs are activated by a high affinity interaction of the Ca 2ϩ /CaM complex with the regulatory domain which removes the autoinhibitory sequence from the active site.
Many details concerning the regulation of the CaMK family have come from mutagenesis studies of MLCK, CaMKI, CaMKII, and CaMKIV (23, 24, 26, 27, 29 -31) and from the recent determination of the crystal structure of CaMKI in its autoinhibited form (28) . CaMKI is a monomeric enzyme of ϳ42 kDa that has widespread tissue distribution and that can phosphorylate a number of substrates including synapsin I, synapsin II (32, 33) , and CREB, the cAMP-response element-binding protein (34) . In the crystal structure of a truncated autoinhibited fragment of CaMKI, the regulatory domain (residues Ile 286 -Met 316 ) binds to the catalytic domain via an ␣R1-helixloop-␣R2-helix structure not observed in other protein kinases (28) . Hydrophobic residues in the ␣R1 helix interact with a hydrophobic channel on the surface of the COOH-terminal lobe of the catalytic domain. Following ␣R1, the regulatory domain does not enter the active site, but instead turns away to form a protuberant loop (residues 300 -304) that includes Trp 303 . The ␣R2 helix (residues 305-316) then unexpectedly interacts with the outside of the ATP-binding loop in the NH 2 -terminal lobe of the catalytic domain, resulting in a striking distortion of this loop. Thus the regulatory domain of CaMKI forms multiple interactions with the catalytic domain that appear likely to interfere with both peptide substrate and MgATP binding.
In addition to their regulation by CaM, CaMKI and CaMKIV are activated by phosphorylation by a highly specific CaMKK at an equivalent threonine (Thr 177 in CaMKI) in the so-called "activation-" or "T-loop", present near the active site of both kinases (7) (8) (9) (10) (11) (12) (13) (14) (15) . The phosphorylation of CaMKI by CaMKK is dependent on CaM in two distinct ways. CaMKK must bind to CaM to be active. In addition, CaMKK cannot phosphorylate Thr 177 of CaMKI unless CaM is bound to the substrate enzyme (10, 35) . Notably, in the structure of the autoinhibited form of CaMKI, the activation loop, although disordered, appears to be accessible (28) .
The crystal structure of CaMKI has suggested a general model of autoinhibition of enzyme activity. To address the function played by specific amino acids in the autoinhibition of CaMKI, and also in its activation by CaM and phosphorylation by CaMKK, we have carried out a detailed structure-function analysis of the regulation of CaMKI, using recombinant wildtype and mutants forms of CaMKI and CaMKK. The results obtained from these enzymatic studies of full-length CaMKI, together with the crystal structure of the autoinhibited enzyme, provide a detailed model for the regulation of this enzyme by CaM and phosphorylation.
EXPERIMENTAL PROCEDURES
Materials-ATP, Nonidet P-40, dithiothreitol, 2-mercaptoethanol, EDTA, EGTA, Tris, Coomassie Brilliant Blue R-250, SDS, and bovine serum albumin were from Sigma. HEPES, phenylmethylsulfonyl fluoride were from Calbiochem. [␥ 32 P]ATP was from NEN Life Science Products. Thin layer cellulose sheets were from Eastman Kodak. Phosphocellulose P-81 paper was from Whatman. CaM was purified from rabbit brain as described (36) . Recombinant CaMKIV expressed in Sf9 cells was kindly provided by Dr. Anthony Means.
Synthesis of Peptides-The peptide YLRRRLSDSNF-amide (corresponding to residues 3-13 of synapsin I) and the peptide encompassing residues 10 -29 of CaMKK␣ (QDPRAELVERVAAISVAHLE) (15) were synthesized by the Keck Foundation Biopolymer Facility at Yale University. The peptides were purified by preparative reversed-phase high performance liquid chromatography, were Ͼ95% pure as analyzed by high performance liquid chromatography, and had the expected amino acid composition and mass spectra.
Cloning of CaMKK␣ cDNA-PC12 mRNA was reverse-transcribed with 10 pmol of random mix primers using an RT-PCR kit (Stratagene). The following oligonucleotides (Operon) were synthesized. Oligo KK-1S corresponded to cDNA encoding rat CaMKK␣ and introduced a BamHI site. Oligo KK-505AS corresponded to the complement of rat CaMKK and introduced an EcoRI site. PCR was performed using: KK-1S (5Ј-CCCGGATCCATGGAGCGCAGTCCAGCCGTC-3Ј) and KK-505AS (5Ј-CCCGAATTCTCAGGATGCAGCCTCATCTTC-3Ј) using the following conditions: 30 cycles 94°C for 1 min, 52°C for 1 min, and 72°C for 2 min. The amplified product was purified using an agarose electrophoresis gel purification kit (Qiagen) and cloned into the TA vector (Invitrogen). CaMKK cDNA and all other deletion or substitution constructs were sequenced by the Rockefeller University DNA sequence Facility.
Construction of COOH-terminal Truncated Mutants of CaMKK-
The following oligonucleotides (Operon) were synthesized: KK-433AS (5Ј-CCCGAATTCTCACTCCTCCTCAGTCACCTC-3Ј), KK-444AS (5Ј-CCC-GAATTCTCACCAGCTGGGGATGAGCTT-3Ј), and KK-457AS (5Ј-C-CCGAATTCTCAACGCTTTCTCAGCATAGA-3Ј).
Oligo KK-433AS, KK-444AS, and KK-457AS correspond to the complements of the coding strand and introduced EcoRI sites. Each deletion mutant was amplified by PCR using the respective primers together with the KK-1S oligonucleotide from 10 ng of CaMKK cDNA using Pfu polymerase (Stratagene). The amplified DNAs were purified by agarose gel electrophoresis and digested with BamHI and EcoRI, and the fragments were subcloned into the BamHI and EcoRI sites of pGEX-2T (Amersham Pharmacia Biotech) using a ligation kit (Takara Shuzo) according to the instructions of the manufacturer.
Construction of COOH-terminal Truncated, and Site-directed, Mutants of CaMKI-CaMKI-299 plasmids and CaMKI-293 were prepared as described (27) . The following oligonucleotides (Operon) were synthesized: KI-1S (5Ј-CCCGGATCCATGCCAGGGGCAGTGGAAGGCCCC-3Ј), KI-297AS (5Ј-CCCGAATTCCTAGTTCTTCTTGATCTGCTCACT-3Ј), and KI-298AS (5Ј-CCCGAATTCCTAAAAGTTCTTCTTGATCTG-CTC-3Ј).
Oligo KI-1S corresponded to cDNA encoding rat CaMKI and introduced a BamHI site. Oligo KI-297AS and KI-298AS corresponded to the complements of the coding strand and introduced EcoRI sites. PCR reactions were performed using pGEX-2T/CaMKI-WT as a template, and the fragments were subcloned into the BamHI and EcoRI sites of pGEX-2T as described above.
Site-directed mutagenesis was carried out using a Quickchange kit (Stratagene) according to the instructions of the manufacturer. pGEX-2T/ CaMKI-WT was used as a template together with the following sense (S) and antisense (AS) primers (mutated bases are underlined): KI-W303S-S (5Ј-GGAAGCTTGCTTCGACTTGCTCTTGGC), KI-W303S-AS (5Ј-GCCAG-GAGCAAGTCGAAGCAAGCTTCC), KI-F307A-S (5Ј-TGGAAGCAAGCT-GCCAATGCTACCGCT), KI-F307A-AS (5Ј-AGCGGTAGCATTGGCAGCT-TGCTTCCA), KI-2A-S (5Ј-AGTGAGCAGGCCAAGAAGAACGCTGCCAA-GAGC), and KI-2A-AS (5Ј-GCTCTTGGCAGCGTTCTTCTTGGCCTGCTC-ACT). For the CaMKI-4A mutant, pGEX-2T/CaMKI-2A served as the template, and the following primers were used: KI-4A-S (5Ј-GATAAGAAT-GCCCACCAGTCAGCCAGTGAGCAG), and KI-4A-AS (5Ј-CTGCTCACTG-GCTGACTGGTGGGCATTCTTATC). PCR was performed under the following conditions: 16 cycles at 95°C for 1 min, 56°C for 1 min and 68°C for 12 min. The reaction mixtures were digested with DpnI for 1 h, then 1 l of digested samples were transfected into XL1 blue Escherichia coli.
Expression and Purification of Recombinant Proteins-BL21 (DE3) cells containing each expression plasmid were grown overnight at 37°C in 100 ml of LB plus 100 g/ml ampicillin. 1 liter of LB plus 100 g/ml ampicillin was inoculated with 100 ml of the overnight culture and incubated at 30°C to an A 600 of 0.6. Isopropyl-1-thio-␤-D-galactopyranoside was added to a final concentration 0.3 mM, and each culture was incubated for 3 h. Cells were harvested by centrifugation at 4,000 ϫ g for 10 min and resuspended in 100 ml of lysis buffer containing 50 mM Tris (pH 7.5), 2 mM dithiothreitol, and 50 g/ml leupeptin. All further steps were carried out at 4°C. Nonidet P-40 and MgCl 2 were added to a final concentration of 0.5% and 5 mM, respectively, cells were lysed using a French press, and lysates were centrifuged at 12,000 ϫ g for 20 min. The supernatants were recovered and applied to a column of glutathione-Sepharose-4B (10 ml wet volume) pre-equilibrated with 20 mM Tris-HCl (pH 7.5), 2 mM MgCl 2 , and 100 M phenylmethylsulfonyl fluoride. The column was washed extensively with equilibration buffer and eluted with 50 mM Tris-HCl (pH 8.8) containing 5 mM glutathione. Fractions were collected, and protein was analyzed by SDS-polyacrylamide gel electrophoresis and staining with Coomassie Brilliant Blue. Fractions containing expressed protein were pooled and dialyzed against equilibration buffer. Protein concentrations were determined using a BCA kit (Pierce). Glycerol was added to 20% (v/v), and aliquots were stored in Ϫ80°C.
Antibody Preparation-An antibody was prepared against a synthetic peptide encompassing residues 10 -29 of CaMKK␣ (QDPRAELV-ERVAAISVAHLE) (15) . Purified peptide was coupled to bovine thyroglobulin using glutaraldehyde. Antisera CC135 was prepared in New Zealand White rabbits by Cocalico Biologicals, Inc. The synthetic peptide was coupled to activated CH-Sepharose beads and used to affinitypurify the sera essentially as described (37) . For immunoblotting, proteins were transferred to nitrocellulose filters as described (38) . Immune complexes were detected by enhanced chemiluminescence (Amersham Pharmacia Biotech).
Phosphorylation Assays-The standard reaction mixture (100 l) contained 50 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM EGTA, 5 mM dithiothreitol, 100 M [␥-32 P]ATP (specific activity, 2-5 ϫ 10 2 cpm/pmol), 1 M CaM, and 1.5 mM Ca 2ϩ . For studies of the phosphorylation of CaMKI or CaMKIV, the final concentrations of kinases in the standard reaction mixtures were: CaMKI, 10 g/ml; CaMKIV, 10 g/ml; and CaMKK, 5 g/ml. After 2 min of preincubation at 30°C, reactions were initiated by the addition of [␥-32 P]ATP. Reactions were terminated by the addition of 100 l of SDS sample buffer (1% SDS, 60 mM Tris-HCl (pH 6.8), 5% (v/v) glycerol, 0.2 M ␤-mercaptoethanol). Samples were analyzed by SDS-PAGE (10% polyacrylamide). Gels were stained with Coomassie Brilliant Blue, destained, dried, and subjected to autoradiography or analysis using a PhosphorImager (Molecular Dynamics). For studies of the effect of phosphorylation on enzyme activity, recombinant CaMKI and CaMKIV (10 g/ml) were preincubated in the absence or presence of CaMKK (2 g/ml) for the indicated times at 30°C under the conditions described above except that nonradioactive ATP was used. A 1/10 volume of each preincubation mixture was aliquoted into a second peptide phosphorylation assay using synapsin I site 1 peptide (100 M) as substrate. Reactions were stopped by addition of acetic acid to a final concentration of 10%, and 32 P-incorporation into the peptide substrate was determined using a standard P-81 filter paper assay. For analysis of the CaM dependence of CaMKI and CaMKIV, enzyme activity was measured using the synapsin I site 1 peptide (100 M) as substrate, and various concentrations of CaM as indicated.
Phosphoamino Acid Analysis-Phosphoamino acid analysis was performed as described (32) . Gel pieces containing 32 P-labeled proteins were excised from dried SDS-polyacrylamide gels and digested with tosylphenylalanyl chloromethyl ketone-trypsin (50 g/ml). Tryptic digests were hydrolyzed with 6 N HCl, and phosphoamino acids were separated on thin layer cellulose sheets (20 ϫ 20 cm) by electrophoresis at pH 1.9 in 8.7% acetic acid, 2.5% formic acid, followed by electrophore-sis in the same direction at pH 3.5 in 10% acetic acid, 1% pyridine. Dried sheets were subjected to autoradiography.
RESULTS

Phosphorylation and Activation of CaMKI and CaMKIV by
CaMKK-The purpose of the present study was to investigate the regulation of CaMKI by CaM and phosphorylation by CaMKK. For these studies, rat CaMKK␣ was cloned from PC12 cells by RT-PCR, and recombinant protein was expressed as a GST-fusion protein. CaMKK␣ was initially identified as an enzyme that could phosphorylate and activate CaMKIV (15, 39) . In addition, CaMKK␣ was found to phosphorylate CaMKI (15, 40) , but information regarding the relative efficiency of phosphorylation of the two substrates was not available. We compared the ability of recombinant CaMKK␣ to phosphorylate and activate CaMKI and CaMKIV ( Figs. 1 and 2) . CaMKI was phosphorylated essentially only on threonine, and CaMKIV was phosphorylated on both serine and threonine (Fig. 1B) . Notably, the total incorporation of 32 P into CaMKIV was much greater than that into CaMKI, but this higher phosphorylation resulted from increased serine phosphorylation, presumably as a result of autophosphorylation of activated CaMKIV (41, 42) . Phosphorylation of either CaMKI or CaMKIV by CaMKK␣ was associated with large increases in enzyme activity that paralleled the phosphorylation of threonine in both enzymes (Fig. 2) . The rate of increase in threonine phosphorylation, as well as the fold-increase in kinase activity, was higher for CaMKI than for CaMKIV, suggesting that CaMKK␣ slightly prefers CaMKI as a substrate compared with CaMKIV.
CaM Dependence of Phosphorylation of CaMKI by CaMKK␣-CaMKK␣, like other CaM kinases, contains putative autoinhibitory and CaM-binding domains following its catalytic domain (15) (Fig. 3A) . It was necessary to define the positions of these regulatory subdomains for use in the studies described below. CaMKK-WT and several COOH-terminal truncations were expressed as recombinant proteins (Fig. 3, A and B). Enzyme activity was measured using CaMKI-293 or CaMKI-WT as a substrate in the absence or presence of Ca 2ϩ / CaM ( Fig. 3C and Fig. 4 ). CaMKI-293 is constitutively active following removal of the autoinhibitory and CaM-binding domains of CaMKI (27) . Consistent with previous studies using a rat brain preparation (10), recombinant CaMKK-WT phosphorylated CaMKI-293 in a Ca 2ϩ /CaM-dependent manner (Fig.  3C) . In contrast, CaMKK-433 was basally active in the absence of Ca 2ϩ /CaM and was slightly inhibited by their addition. Moreover, CaMKK-433 could only phosphorylate CaMKI-WT in the presence of Ca 2ϩ /CaM. CaMKK-457, like CaMKK-WT, phosphorylated CaMKI-293 in a Ca 2ϩ /CaM-dependent manner; however, CaMKK-444 was basally inactive and could not be activated by addition of Ca 2ϩ /CaM. Taken together, these studies indicate that the CaM-binding domain of CaMKK is contained within residues 444 -457, and the autoinhibitory domain is contained within residues 433-444. Similar conclusions have recently been made based on studies of slightly different CaMKK mutants (43) .
The CaM dependence of CaMKK was measured at different concentrations of CaM, and the results were compared with that of CaMKI and CaMKIV (Fig. 4) . Using synapsin I site 1 peptide as substrate, the concentration of CaM required for half-maximal activation (K 0.5 ) of both CaMKI and CaMKIV was ϳ30 nM. Using CaMKI-293 as substrate, the K 0.5 of CaMKK was ϳ5 nM.
Relationship between the Regulation of CaMKI by CaM and Phosphorylation by CaMKK-To further investigate the structural basis for the interrelationship between activation by Ca 2ϩ /CaM and phosphorylation by CaMKK, a number of truncation mutants of CaMKI were prepared (Fig. 5A) , and their phosphorylation by CaMKK-433 was compared with their regulation by CaM. CaMKI-299, which was inactive in either the absence or presence of Ca 2ϩ /CaM (Fig. 5B) , was not phosphorylated by CaMKKI-433 (Fig. 5C) . Removal of A299 to produce CaMKI-298, maintained the enzyme in its autoinhibited form. Moreover, CaMKI-298 was not phosphorylated by CaMKK-433. However, removal of Phe 298 to produce CaMKI-297, generated an enzyme that was not only constitutively active but was also phosphorylated by CaMKK-433. Notably, the activity of CaMKI-297 and the level of phosphorylation of this mutant by CaMKK-433 was slightly lower than that of CaMKI-293 (Fig. 5 and data not shown) . CaMKI-294 exhibited essentially the same properties as CaMKI-293 (data not shown), suggest-
FIG. 1. Phosphorylation of CaMKI and CaMKIV by CaMKK.
A, GST-CaMKI (10 g/ml) and CaMKIV (10 g/ml) were incubated with CaMKK (5 g/ml) for the indicated times as described under "Experimental Procedures." Proteins were separated by SDS-PAGE (10% polyacrylamide), and autoradiography was performed. Recombinant GSTCaMKK does not autophosphorylate under these conditions. The phosphorylation of CaMKK observed is mediated by either activated CaMKI or CaMKIV (M. Matushita and A. C. Nairn, unpublished results). B, phosphoamino acid analysis of phosphorylated CaMKI and CaMKIV. Samples of CaMKI and CaMKIV phosphorylated by CaMKK for the times shown in panel A were digested with trypsin, and phosphoamino acid analysis was performed.
32 P-phosphoamino acids were detected by autoradiography. Phosphotyrosine (pY), phosphothreonine (pT), and phosphoserine (pS) standards were detected by staining with ninhydrin.
ing that residues 295-297 may contribute slightly to autoinhibition.
Role of Hydrophobic Amino Acids in the Autoinhibition and Activation of CaMKI-Based on detailed structural studies of the interaction of model CaM-binding peptides with CaM (44 -46) , the crystal structure of CaMKI suggested that Trp 303 , which is positioned so that the side chain points outward into solvent, might act as an initial target for CaM. Unexpectedly, in the crystal structure of CaMKI, Phe 307 in the CaM-binding domain was found in contact with Phe 31 , a residue conserved in the ATP-binding loop of many protein kinases including PKA, leading to distortion of the ATP-binding domain in the active site of the kinase. This suggested that the CaM-binding domain, in addition to binding CaM, might also contribute to the autoinhibition of the enzyme. To further investigate the role of these two hydrophobic amino acids, site-directed mutagenesis of CaMKI-WT was carried out (Fig. 6A) , and the effect of the various mutations on activation by CaM was examined (Fig.  6B) . Replacement of Trp 303 with serine (CaMKI-W303S) resulted in a large increase in the K 0.5 for CaM from ϳ30 nM for CaMKI-WT to Ͼ100 M for CaMKI-W303S, consistent with the proposed role of Trp 303 as an initial target for CaM. Replacement of Phe 307 with alanine (CaMKI-F307A) resulted in an increase in the basal CaM-independent activity of the enzyme. Notably, for the CaM-dependent component of activation, there was no significant change in the K 0.5 for CaM, although a small leftward shift in the CaM activation curve was consistently observed. In addition, there was no significant change in the apparent K m for MgATP for CaMKI-W307A (measured in the absence of Ca 2ϩ /CaM) compared with CaMKI-WT (measured in the presence of Ca 2ϩ /CaM) (data not shown). The results described in Fig. 5 and Phe 298 with alanine (CaMKI-2A) resulted in an increase in the basal activity of the mutant (Fig. 6B) . Additional mutation of Ile 286 and Val 290 (CaMKI-4A) resulted in a further increase in the basal activity of enzyme activity. For both mutants, there was no significant change in the K 0.5 for CaM, although like CaMKI-F307A, small leftward shifts in the CaM activation curves were consistently observed. In addition, there were no significant changes in the apparent K m for peptide substrate for CaMKI-2A or -4A (measured in the absence of Ca 2ϩ /CaM) compared with CaMKI-WT (measured in the presence of Ca 2ϩ / CaM) (data not shown). However, notably, CaMKI-2A and CaMKI-4A, but not CaMKI-F307A (Fig. 6C) or CaMKI-W303S (data not shown), were phosphorylated at Thr 177 by CaMKK-433.
DISCUSSION
The results obtained from the present enzymatic studies using full-length CaMKI provide strong support for the mechanism of autoinhibition and activation by CaM that was suggested by the crystal structure of the truncated kinase. The results also provide insight into the interrelationship between the autoinhibition of CaMKI and the phosphorylation of the T-loop by CaMKK.
An important observation made in this study is that, in the truncated form of the kinase, Phe 298 alone is sufficient to maintain CaMKI in an inactive, autoinhibited state. This result extends previous deletion mutagenesis studies that had indicated a role for residues 294 -299 in autoinhibition of CaMKI (10, 27) . The consensus amino acid sequence found in substrates for CaMKI is Hyd-B-Arg-B-X-Ser/Thr-X-X-X-Hyd (where X is any amino acid, B is preferably a basic residue, Hyd is a hydrophobic residue, and Ser/Thr represents the residue phosphorylated at the P0 position) (47) . 2 In the crystal structure of autoinhibited CaMKI, Lys 300 interacts with Glu
102
, and we have suggested that Lys 300 mimics the P-3 basic amino acid in the peptide substrate (28), a suggestion supported by the observation that mutation of Glu 102 alters the P-3 specificity of the enzyme. 2 In the autoinhibited form of CaMKI, Phe 298 interacts with a hydrophobic pocket formed by Ile 210 , Pro 216 , and Phe 104 . We interpret our results to suggest that the interaction of Phe 298 , or the P-5 hydrophobic amino acid in the substrate, with the hydrophobic pocket in the catalytic core, is likely to be mutually exclusive. In addition, this interaction of the P-5 hydrophobic residue with the catalytic core of the enzyme most likely defines the NH 2 -terminal boundary for binding of peptide substrate.
For the CaMKs, as well as certain other CaM-binding proteins, two hydrophobic residues 8 -12 amino acids apart form important targets for interaction with CaM (44 -46) . The interaction with CaM is bipartite; the NH 2 -terminal hydrophobic residue interacts primarily with the COOH-terminal domain of CaM, whereas the COOH-terminal hydrophobic residue interacts with the NH 2 -terminal domain of CaM. In several cases, the NH 2 -terminal hydrophobic amino acid in CaM-binding pep- tides is a tryptophan. Mutation of Trp 303 of CaMKI resulted in a large decrease in the K 0.5 for CaM. This result, together with the fact that the side-chain of Trp 303 points outward from the catalytic core in the crystal structure of CaMKI, is consistent with this residue being the initial target for the COOH-terminal domain of CaM and that this interaction is important for the normal activation of the enzyme. Based on the structures of CaM in complexes with different CaM-binding peptides (44 -46) and truncation mutagenesis studies of CaMKI (10, 27) 
FIG. 3. Construction and expression of a series of COOH-terminal truncated mutants of CaMKK as GST fusion proteins.
A, schematic representation of wild type CaMKK and mutant enzymes. A series of DNAs were amplified using PCR from a cDNA encoding rat CaMKK␣ as described under "Experimental Procedures". The DNA fragments were subcloned into pGEX-2T and expressed in E. coli as GST fusion proteins. B, recombinant CaMKK mutants (0.1 g) were separated by SDS-PAGE (10% polyacrylamide) and analyzed by immunoblotting using an antibody that recognizes the NH 2 terminus of CaMKK␣. C, CaMKI-293 (10 g/ml) and CaMKI-WT (10 g/ml) were incubated with CaMKK␣ mutants (5 g/ml) as indicated, for 60 min, at 30°C in the absence or presence of 1.5 mM CaCl 2 , 1 M CaM as described under "Experimental Procedures." Proteins were separated by SDS-PAGE (10% polyacrylamide), and autoradiography was performed. The low level of incorporation of , CaMKIV (0.1 g/ml) and CaMKK-WT (5 g/ml) were assayed in the presence of 1 mM CaCl 2 with the indicated concentrations of CaM. For CaMKI and CaMKIV, synapsin I site 1 peptide was used as substrate. For CaMKK-WT, CaMKI-293 (50 g/ml) was used as substrate.
32 P-incorporation into peptide was determined as described under "Experimental Procedures." 32 P-incorporation into CaMKI-293 was determined by PhosphorImager analysis with basal phosphorylation of CaMKI-293 being subtracted.
Therefore, in the full-length enzyme, binding of the COOHterminal domain of CaM to CaMKI would be sufficient to remove the pseudosubstrate domain, including Phe 298 and Lys
300
, from the catalytic core of the enzyme. (28) . The involvement of hydrophobic amino acids in the interaction of the regulatory domain with the catalytic domain was unexpected because several previous studies of CaMK regulation had focused on potential roles for basic amino acids in mediating charge-based pseudosubstrate interactions (23, 24, 49 . Mutation of several hydrophobic amino acids in the NH 2 -terminal region of CaM also increased the K 0.5 for the CaM mutants. More interestingly, three of these mutants could not fully activate CaMKI even at high concentrations, an effect that was apparently caused by increases in the K m for ATP for CaMKI. This dependence of the K m for ATP on alteration of the NH 2 terminus of CaM is consistent with the idea that interaction of residues 307-316 of CaMKI with the ATP-binding domain is likely to perturb ATP binding to the enzyme, and to contribute to an additional level of autoinhibition.
The results obtained in the present study indicate that the mechanisms involved in autoinhibition of CaMKI are also important for regulating the phosphorylation of the enzyme by CaMKK. Thus, removal of a single amino acid, Phe 298 , (in the truncated form of CaMKI) resulted in a constitutively active enzyme and generated a substrate for CaMKK-433. In the crystal structure of autoinhibited CaMKI, the T-loop that contains the threonine residue phosphorylated by CaMKK (Thr   177   ) is disordered, although apparently exposed to solvent. Phe 298 is situated at the COOH-terminal end of ␣R1, some distance from Thr 177 , and it does not appear possible that Phe 298 can influence the organization of the T-loop via any direct interaction. CaMKK must therefore recognize structural elements of fully active CaMKI that are only present in the truncated active enzyme, or in CaMKI-WT in the presence of CaM, once the . Notably, acidic residues in domains V and VI (Glu 102 and Glu 145 of CaMKI), that are important for recognition of basic amino acids within substrate recognition motifs for CaMKI, CaMKII, CaMKIV, and PKA, are not conserved in CaMKK (15) . This supports the idea that CaMKK must utilize other distinct interactions for recognition of its substrates, CaMKI and CaMKIV. This would be consistent with studies of enzymes in the various MAP kinase pathways that have revealed that protein-protein interactions away from the active site of the upstream kinase, and away from the T-loop of the downstream substrate, are important for directing the specificity of a kinase cascade (53-55).
The discovery that CaMKI and CaMKIV are regulated by T-loop phosphorylation is not surprising, given that this is a mechanism that is common to many protein kinases. However, the physiological significance of the coupling of two protein kinases that are both tightly regulated by CaM is not clear at this time. In many respects the regulation of CaMKK and CaMKI by CaM is analogous to that of 5Ј-AMP activated protein kinase kinase (AMPKK) which phosphorylates and activates 5Ј-AMP activated protein kinase (AMPK) (56) , or 3-phosphoinositide-dependent protein kinase (PDK1) which phosphorylates and activates protein kinase B (PKB) (57, 58) . Studies of the protein kinase cascades involved in the regulation of glycogen metabolism and the MAP kinases suggest that one function of a cascade is signal amplification (59 -61) . Theoretical analysis of the MAP kinase cascade also suggests that cooperative relationships between enzymes leads to a more FIG. 6 . CaM dependence of CaMKI-WT and CaMKI regulatory domain mutants. A, comparison of the amino acid sequences of CaMKI-WT and CaMKI mutants. B, CaMKI (0.1 g/ml) and CaMKI regulatory domain mutants (0.1 g/ml) were assayed in the presence of 1 mM CaCl 2 with the indicated concentrations of CaM using synapsin I site 1 peptide as substrate. Activity is normalized to that of fully active CaMKI-WT. Except for CaMKI-W303S, the maximal activity of CaMKI-WT and the other mutants was identical. C, CaMKI mutants (1 g/ml) were incubated with CaMKK-433 (0.5 g/ml) in the absence of Ca 2ϩ /CaM as described under "Experimental Procedures." Samples were analyzed by SDS-PAGE (10% polyacrylamide), and autoradiography was performed. The low level of incorporation of 32 P into CaMKI-WT and CaMKI-F307A reflects a low level of autophosphorylation of these mutants. switch-like response at the final point of the cascade (60, 61) . The present study suggests that CaMKK has an intrinsically higher apparent affinity for CaM than dephospho-CaMKI (summarized in Fig. 7) , raising the possibility that it would be activated at lower Ca 2ϩ concentrations within cells (62) . However, CaM must bind to CaMKI before CaMKK can phosphorylate Thr 177 thereby placing a constraint on the ability of active CaMKK to interact with its substrate. Studies of CaMKII have shown that autophosphorylation of Thr 286 leads to a significant increase in the affinity of that enzyme for CaM and that this may be responsible for the ability of CaMKII to decode oscillatory Ca 2ϩ signals (63, 64) . However, studies of CaMKI 3 and CaMKIV (35) indicate that phosphorylation of either enzyme by CaMKK does not affect their affinity for CaM. Kinetic analysis of the activities of dephospho-and phosphoCaMKI indicate that phosphorylation by CaMKK is accompanied by a large increase in catalytic efficiency that is associated with a reduced K m and an increased k cat (Fig. 7) . 2 Therefore it is likely that the physiologically relevant form of CaMKI is the fully phosphorylated and CaM-bound form of the enzyme. The differential activation of CaMKK and CaMKI by CaM may therefore ensure that CaMKI is only activated at relatively high concentrations of Ca 2ϩ . Alternatively, activation of CaMKI may occur only as a consequence of repeated increases in intracellular Ca 2ϩ , as would occur, for example, during tetanic stimulation in neurons.
In conclusion, the results from the present study as well as those of the recent study of CaM mutants (52) support a model in which the COOH-terminal region of CaM initially binds to the exposed Trp 303 of autoinhibited CaMKI. This initial interaction with CaM is likely to be sufficient to remove the region of ␣R1, including Phe 298 , that makes pseudosubstrate contacts with the P-5 and P-3 amino acid binding sites. This may allow peptide substrate to begin to bind to the enzyme. However, additional interaction of the NH 2 -terminal region of CaM with ␣R2 is necessary to release the ATP-binding region from its constrained position. Although kinetic analyses of PKA have indicated that random binding of peptide or MgATP is possible, thermodynamic and structural considerations suggest that MgATP is likely to bind prior to peptide (50, 51, 65) . The reorientation of the ATP-binding site is likely to be associated with rotation of the two lobes of CaMKI that will result in a closed "active" conformation. Removal of Phe 298 from the P-5 binding site alone, or in combination with the reorientation of the ATP-binding domain, is also associated with conformational changes that allow the T-loop to be phosphorylated. In turn, as revealed by recent studies of phosphorylase kinase and the insulin receptor tyrosine kinase (66, 67) , the phosphorylated T-loop is likely to form an antiparallel ␤-sheet structure that fully defines the binding sites for Pϩ1 to Pϩ4 amino acids in the peptide substrate. Future structural studies will hopefully reveal additional details of this mechanism of regulation of CaMKI and address the general application of the mechanism to the regulation of other CaMKs.
